Complete resection with clear margins remains the treatment of choice for pediatric synovial sarcoma, with adjuvant radiation therapy potentially beneficial for specific IRS groups.
No takes yet. Share an insight, caveat, or question.
May support IRS-based risk stratification in pediatric synovial sarcoma; leaves open optimal adjuvant strategies pending prospective data.
Andrassy et al. (2001) studied this question.